Pharma channel feed

Celebri­ty en­dorse­ments lift Idor­sia, Pfiz­er and No­var­tis TV ads to most ef­fec­tive for phar­ma in 2023, analy­sis finds

Last year
Marketing

Te­va plans sale of API unit amid 'piv­ot to growth'

Last year
Manufacturing

Ther­mo Fish­er’s Q4 rev­enue dips due to ‘still mut­ed’ mar­ket

Last year
Manufacturing

Bio­gen to halt sales and de­vel­op­ment of con­tro­ver­sial Alzheimer's drug Aduhelm

Last year
R&D

No­vo Nordisk con­tin­ues di­a­betes, obe­si­ty sales rise, but still on the back foot with We­govy sup­ply

Last year
Manufacturing

Up­dat­ed: GSK takes vic­to­ry lap with block­buster sales for RSV vac­cine

Last year

Up­dat­ed: No­var­tis ax­es blood can­cer drug af­ter PhI­II flop, cau­tions on obe­si­ty FO­MO

Last year
R&D

Ver­tex's next chal­lenge for pain pill? Crack­ing a mar­ket dom­i­nat­ed by cheap opi­oids

Last year

Three burn­ing 2024 ques­tions for Pfiz­er: What to do in weight loss, the hunt for megablock­busters, and in­te­grat­ing the deals

Last year

FDA re­jects mo­tion sick­ness drug from De­fend­er Phar­ma

Last year
FDA+

Sen­a­tor turns up heat on in­haler man­u­fac­tur­ers to re­move im­prop­er­ly list­ed Or­ange Book patents

Last year
FDA+

Cre­ative AI gains steam among phar­ma mar­keters in­clud­ing Sanofi, No­var­tis, al­though con­cerns abound

Last year
AI
Marketing

Mar­ket­ingRx roundup: Astel­las menopause drug led NFL TV spend­ing; A pod­cast's deep dive in­to Novo's his­to­ry

Last year
Marketing

Ex­clu­sive: Eli Lil­ly sup­plied schiz­o­phre­nia drug to un­cer­ti­fied health­care providers, Form 483 shows

Last year
FDA+

Pfiz­er's Q4 rev­enue tum­bles 42% amid Covid re­set

Last year

Gilead in­vests an­oth­er $320M in Ar­cus as part­ners re­hash their TIG­IT pact

Last year
Deals
R&D

Ju­ry awards Nat­era $96M+ in blood test patent fight

Last year
Law

GSK shoots for RSV la­bel ex­pan­sion in younger adults in Eu­rope in race against Pfiz­er’s Abrys­vo

Last year
FDA+

Bris­tol My­er­s' Op­di­vo fails part two of post-kid­ney can­cer surgery test as com­peti­tor Mer­ck touts new sur­vival da­ta

Last year
R&D

Two new drugs get pos­i­tive rec­om­men­da­tions from EMA com­mit­tee, while two oth­ers get thumbs-down

Last year
FDA+

Com­pe­ti­tion en­force­ment led to fair­er prices, in­no­v­a­tive prod­ucts — EC re­port

Last year
FDA+

Check your dad jeans — and genes — in J&J's new BR­CA-fo­cused cam­paign

Last year
Marketing

Sen­ate Fi­nance Com­mit­tee plots ways to tweak Medicare to re­duce ster­ile in­jectable short­ages

Last year

As PBMs face threats in Wash­ing­ton, in­dus­try trade group poured mil­lions more in­to lob­by­ing

Last year
FDA+
First page Previous page 74757677787980 Next page Last page
A service from the Financial Times